Medical Cannabis: a crucial step towards a French ecosystem
![](https://www.stanipharm.com/wp-content/uploads/2022/02/medical-cannabis-France-2022.png)
Pharmaceutical companies qualified to manufacture either active substances or medicines will now be able to produce cannabis-based medicines in France.
A look back at some of 2021’s key highlights at StaniPharm
![](https://www.stanipharm.com/wp-content/uploads/2022/01/StaniPharm-Hghlights-2021-900-300-HD.png)
Manufacturing of clinical GMP batches of a new vaccine adjuvant, development of innovative cannabis-based medicines …
Vaxinano partners with StaniPharm for development and production of its vaccine delivery system
![](https://www.stanipharm.com/wp-content/uploads/2021/01/feature-blog-vaxinano-900-300-2.jpg)
“Scaling up this kind of vaccine delivery system is a crucial step and requires a strong partner” says Dr. Didier Betbeder, CEO of Vaxinano.
Developing a French “patient to seed” ecosystem to improve the therapeutic benefit of medical Cannabis
![](https://www.stanipharm.com/wp-content/uploads/2021/01/Feature-blog-image-Medicinal-Cannabis-StaniPharm-French-Ecosystem.png)
“Simply replacing the imported products currently specified for the pilot program with French-produced equivalents would be a missed opportunity and a disservice to patients”
Cybernano and StaniPharm join forces to develop tomorrow’s health products
![](https://www.stanipharm.com/wp-content/uploads/2021/05/Cybernano-StaniPharm-blog-900-300.png)
The complementary nature of their expertise and technologies will provide complete support for start-ups and SMEs from development through clinical trials.
Drug nanoparticles – a common approach to tackle the poor aqueous solubility of APIs
![](https://www.stanipharm.com/wp-content/uploads/2021/01/featured-image-nano.jpg)
Nanosizing drug particles brings key benefits for oral formulations of poorly soluble drugs such as Biopharmaceutics Classification System (BCS) Class II drugs.
8 supercritical companies inspired by Michel Perrut, founder of SEPAREX
![](https://www.stanipharm.com/wp-content/uploads/2021/01/LICOSEP-8-200-900-300.jpg)
SEPAREX, the gold standard in supercritical fluids, was founded in 1985 by Michel Perrut.
SEPAREX was also a pioneering business incubator, far ahead of its time, contributing to the birth of 8 companies.